223488-57-1 Usage
Description
2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid is a complex organic compound with a unique molecular structure that features a phenoxy group connected to a carboxylic acid moiety. This molecule is characterized by the presence of a tert-butylbenzyl group and a pyridin-3-ylsulfonyl group, which contribute to its specific properties and potential applications.
Uses
Used in Pharmaceutical Industry:
2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid is used as a pharmaceutical agent for the development of drugs targeting specific receptors or pathways. Its unique structure allows for the modulation of biological processes, making it a promising candidate for the treatment of various diseases.
Used in Drug Discovery and Development:
In the field of drug discovery and development, 2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid serves as a lead compound for the design and synthesis of new therapeutic agents. Its chemical properties and structural features can be further optimized to enhance its efficacy, selectivity, and safety profile.
Used in Research Applications:
2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid is also utilized in research settings to study the mechanisms of action and potential interactions with biological targets. This knowledge can contribute to a better understanding of disease pathways and the development of more effective treatments.
Used in Bone Growth Induction:
As an EP2 receptor selective prostaglandin E2 agonist, 2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid, also known as Evatanepag, is used for inducing bone growth. This application is particularly relevant in the treatment of conditions that involve bone loss or impaired bone formation, such as osteoporosis or fractures.
Check Digit Verification of cas no
The CAS Registry Mumber 223488-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,4,8 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 223488-57:
(8*2)+(7*2)+(6*3)+(5*4)+(4*8)+(3*8)+(2*5)+(1*7)=141
141 % 10 = 1
So 223488-57-1 is a valid CAS Registry Number.
223488-57-1Relevant articles and documents
POLYMORPHS OF PROSTAGLANDIN AGONISTS AND METHODS FOR MAKING THE SAME
-
Page/Page column 13-14, (2009/04/25)
The present invention relates to polymorphic crystalline forms or a non- crystalline form or amorphous of the compound (3-(((4-tert-butyl-benzyl)-(pyridine- 3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof together with pro
Methods of treatment using an EP2 selective receptor agonist
-
Page/Page column 37, (2010/02/13)
The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.
Controlled release polymeric compositions of bone growth promoting compounds
-
, (2008/06/13)
The present invention is directed to an improved system for controlled release of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
